BioCentury
ARTICLE | Clinical News

CARN 700: Began Phase I trials

January 2, 1996 8:00 AM UTC

Carrington Laboratories Inc. (CARN), Irving, Texas Product: CARN 700, complex polysaccharide for injection Indication: Various cancers, including breast, prostate, colon, soft tissue sarcoma, melanoma...